123 related articles for article (PubMed ID: 21183892)
1. The safety and oncologic efficacy of radio-frequency ablation for the treatment of small renal masses: comprehensive review of the current literature.
Tailly T; Goeman L; Gontero P; Joniau S
Panminerva Med; 2010 Dec; 52(4):319-29. PubMed ID: 21183892
[TBL] [Abstract][Full Text] [Related]
2. Kidney radiofrequency ablation for small renal tumors: oncologic efficacy.
Joniau S; Tailly T; Goeman L; Blyweert W; Gontero P; Joyce A
J Endourol; 2010 May; 24(5):721-8. PubMed ID: 20477540
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
Joniau S; Tsivian M; Gontero P
Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
[TBL] [Abstract][Full Text] [Related]
4. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
6. Current status of renal radiofrequency ablation.
Carraway WA; Raman JD; Cadeddu JA
Curr Opin Urol; 2009 Mar; 19(2):143-7. PubMed ID: 19188768
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
8. Current status of minimally invasive ablative techniques in the treatment of small renal tumours.
Mouraviev V; Joniau S; Van Poppel H; Polascik TJ
Eur Urol; 2007 Feb; 51(2):328-36. PubMed ID: 17069964
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
11. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
[TBL] [Abstract][Full Text] [Related]
12. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation.
Goel RK; Kaouk JH
Curr Opin Urol; 2008 Sep; 18(5):467-73. PubMed ID: 18670269
[TBL] [Abstract][Full Text] [Related]
13. Does renal mass ablation provide adequate long-term oncologic control?
Faddegon S; Cadeddu JA
Urol Clin North Am; 2012 May; 39(2):181-90, vi. PubMed ID: 22487761
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for treatment of renal tumors: technological principles and outcomes.
Salas N; Castle SM; Leveillee RJ
Expert Rev Med Devices; 2011 Nov; 8(6):695-707. PubMed ID: 22029467
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
16. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
[TBL] [Abstract][Full Text] [Related]
17. Novel methods for renal tissue ablation.
Olweny EO; Cadeddu JA
Curr Opin Urol; 2012 Sep; 22(5):379-84. PubMed ID: 22706069
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of small renal masses.
Volpe A; Cadeddu JA; Cestari A; Gill IS; Jewett MA; Joniau S; Kirkali Z; Marberger M; Patard JJ; Staehler M; Uzzo RG
Eur Urol; 2011 Sep; 60(3):501-15. PubMed ID: 21664040
[TBL] [Abstract][Full Text] [Related]
20. Ablative therapies in the treatment of small renal tumors: how far from standard of care?
Gontero P; Joniau S; Zitella A; Tailly T; Tizzani A; Van Poppel H; Kirkali Z
Urol Oncol; 2010; 28(3):251-9. PubMed ID: 19897385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
